Dead-Space Microdomains as Explicit Barriers to Extracellular Drug Transport in Alzheimer’s Disease

Dimitrios Charemis, Dimitrios Lampropoulos, Yannis Dimakopoulos, Gregory Sivolapenko, Maria Hadjinicolaou

Open source

DOI
10.1007/s11095-026-04129-w
Published
2026-06-09
Container
Pharmaceutical Research
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11095-026-04129-w,
  title = {Dead-Space Microdomains as Explicit Barriers to Extracellular Drug Transport in Alzheimer’s Disease},
  author = {Dimitrios Charemis and Dimitrios Lampropoulos and Yannis Dimakopoulos and Gregory Sivolapenko and Maria Hadjinicolaou},
  year = {2026},
  journal = {Pharmaceutical Research},
  doi = {10.1007/s11095-026-04129-w},
  url = {https://doi.org/10.1007/s11095-026-04129-w}
}

RIS

TY  - JOUR
TI  - Dead-Space Microdomains as Explicit Barriers to Extracellular Drug Transport in Alzheimer’s Disease
AU  - Dimitrios Charemis
AU  - Dimitrios Lampropoulos
AU  - Yannis Dimakopoulos
AU  - Gregory Sivolapenko
AU  - Maria Hadjinicolaou
PY  - 2026
JO  - Pharmaceutical Research
DO  - 10.1007/s11095-026-04129-w
UR  - https://doi.org/10.1007/s11095-026-04129-w
ER  - 

APA

Charemis, D., Lampropoulos, D., Dimakopoulos, Y., Sivolapenko, G., & Hadjinicolaou, M. (2026). Dead-Space Microdomains as Explicit Barriers to Extracellular Drug Transport in Alzheimer’s Disease. Pharmaceutical Research. https://doi.org/10.1007/s11095-026-04129-w

Source records